Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

74
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
74

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Self-Assembling Aromatic Peptide Amphiphile Fibers for Multivalent Display of Enzymatically Linked Antigenic Proteins.

ACS applied materials & interfaces·2025
Same author

Peptide Materials.

Biomacromolecules·2025
Same author

Drug-Inspired Design of Supramolecular Polymers for Enhanced Drug Loading and Sustained Therapeutic Release.

ACS nano·2025
Same author

Effective communication with JCR editors in the peer review process.

Journal of controlled release : official journal of the Controlled Release Society·2025
Same author

Balancing Chemical and Supramolecular Stability in OEGylated Supramolecular Polymers for Systemic Drug Delivery.

Journal of the American Chemical Society·2025
Same author

Self-Assembling Peptides, Conjugates, and Mimics: A Versatile Platform for Materials and Beyond.

Accounts of chemical research·2025

Related Experiment Video

Updated: Mar 20, 2026

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.5K

Progress in the Development of Nanotheranostic Systems.

Honggang Cui1, Jun Wang2

  • 11. Department of Chemical and Biomolecular Engineering, and Institute for NanoBioTechnology, The Johns Hopkins University, 3400 North Charles Street, Baltimore, Maryland 21218, United States; 2. Department of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States; 3. Center for Nanomedicine, The Wilmer Eye Institute, Johns Hopkins University School of Medicine, 400 North Broadway, Baltimore, Maryland 21231, United States.

Theranostics
|May 25, 2016
PubMed
Summary

Nanostructures are advancing therapeutic, diagnostic, and theranostic systems. This issue overviews recent progress in these nanostructure-based innovations.

Keywords:
Nanotheranosticsnanostructure

More Related Videos

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

8.8K
Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.6K

Related Experiment Videos

Last Updated: Mar 20, 2026

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.5K
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

8.8K
Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.6K

Area of Science:

  • Nanotechnology and Materials Science
  • Biomedical Engineering
  • Drug Delivery and Nanomedicine

Background:

  • This thematic issue focuses on nanostructure-based systems for medical applications.
  • It encompasses both review and research articles to provide a comprehensive overview.
  • The scope covers therapeutic, diagnostic, and theranostic applications of nanostructures.

Discussion:

  • Nanostructures offer unique properties for targeted drug delivery and enhanced imaging.
  • The development of theranostic systems integrates diagnostic and therapeutic capabilities.
  • Challenges in clinical translation and scalability are implicitly addressed through research findings.

Key Insights:

  • Recent advancements highlight novel nanocarriers for improved drug efficacy and reduced side effects.
  • New diagnostic nanoprobes show enhanced sensitivity and specificity in disease detection.
  • Integrated theranostic platforms demonstrate potential for personalized medicine.

Outlook:

  • Future research will likely focus on biocompatible and biodegradable nanostructures.
  • Clinical translation of nanomedicines is expected to accelerate with further validation.
  • The integration of artificial intelligence in nanomedicine design is a promising avenue.